Government and academic investigators have developed a vaccine against African swine fever that appears to be far more effective than previously developed vaccines. The research appears this week in the Journal of Virology, a publication of the American Society for Microbiology.
Currently, there is no commercially available vaccine against African swine fever, which has been devastating the swine industry in Eastern Europe and Southeast Asia. African swine fever virus (ASFV) is highly contagious and often lethal to domestic and wild pigs. Outbreaks have been quelled — more or less — “by animal quarantine and slaughter,” according to the report. (Humans are not susceptible to ASFV.)